- Poster presentation
- Open Access
Effectiveness of premedication for hypersensitivity reactions to radiocontrast media in one tertiary hospital
© Jung et al; licensee BioMed Central Ltd. 2014
- Published: 18 July 2014
- Public Health
- Medical Record
- Electronic Medical Record
For patients with a known history of hypersensitivity reactions to radiocontrast media (RCM), premedication with antihistamines and corticosteroids before receiving RCM is recommended. It has been shown that such premedication decreases the frequency of mild and aggregate allergic like reactions. However, premedication does not prevent all subsequent reactions.
We investigate the effectiveness of premedication for hypersensitivity reactions to radiocontrast media (RCM) in one tertiary hospital.
We reviewed electronic medical records of all the patients who had been prescribed premedication with systemic steroid or antihistamine for hypersensitivity reactions to RCM from January 2009 to January 2012 in Seoul National University Hospital. Data of previous hypersensitivity reactions and reactions after re-exposure to RCM with premedication was extracted.
A total of 401 patients with a history of hypersensitivity reaction to RCM and were premedicated at re-exposure to RCM. Male was 177 (44.1%) and mean age was 55.83¡¾11.92 years. Most common hypersensitivity symptom was urticaria (259, 64.6%), followed by itching (36.7%), rash (21.4%) and angioedema (13.2%). Hypotension was reported in 9 (2.2%) and syncope 5 (1.2%). Systemic steroid was prescribed in 143 patients (35.4%). After premedication, 139 patients (77.7%) had no hypersensitivity reactions to re-exposed RCM. Incidence of symptom after premedication such as uriticaria (12.4%), itching (5.6%), rash (5.1%), angioedema (2.2%) were significantly decreased compared with previous incidence (P<0.001). However, incidence of hypotension (1.1%) and syncope (0.6%) were no significant different with previous incidence (P>0.05)
The use of corticosteroid or antihistamine before administration of RCM may diminish the overall prevalence of reactions. Randomized controlled studies of the effects of pretreatment in patients with hypersensitivity reaction to RCM were needed.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.